Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
At least 20 states that have limited gender-affirming treatment for minors.
Americans are uprooting their lives in response to a legislation across the country restricting health care for transgender people.
Apretude for HIV prevention is as effective for trans women as it is for gay men, with no adverse effects on hormone therapy.
Feminizing hormones used by transgender women living with HIV may alter susceptibility to heart disease.
A study suggests that pre-exposure prophylaxis (PrEP) pills work at full potency in women of trans experience who use feminizing hormones.
Studies offer reassurance that transgender women can safely and effectively use PrEP with hormone therapy.
The “No Data No More” manifesto explains why it’s vital to include more transgender people in HIV prevention research. [VIDEO]
Study will test whether providing both together will improve HIV protection for trans women.
The REPRIEVE study, which is primarily looking at a statin’s effect on cardiovascular disease, is shedding light on many other mysteries.
PrEP may be less effective among trans women compared with men who have sex with men.
Will gender-changing hormones neuter your HIV regimen?
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.